Glipizide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Glipizide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

GLIPIZIDE DESCRIPTION



Glipizide





CLINICAL PHARMACOLOGY

Mechanism of Action



Effects on Blood Glucose




Other Effects



PHARMACOKINETICS

Pharmacokinetics and Metabolism




INDICATIONS & USAGE



GLIPIZIDE CONTRAINDICATIONS





WARNINGS






PRECAUTIONS

General







LABORATORY TESTS



INFORMATION FOR PATIENTS





Physician Counseling Information for Patients


DRUG INTERACTIONS





CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Pregnancy Category C:



Nonteratogenic Effects:


NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE

CLINICAL PHARMACOLOGYDOSAGE AND ADMINISTRATION

GLIPIZIDE ADVERSE REACTIONS



PRECAUTIONSOVERDOSAGE
































OVERDOSAGE



DOSAGE & ADMINISTRATION








PRECAUTIONS








HOW SUPPLIED








SPL PATIENT PACKAGE INSERT






  • ●     your body may not be making enough insulin
  • ●     your body may not be using the insulin that you have already made
  • ●     the level of sugar in your blood is too high


  • ●     helping the body release more of its own insulin
  • ●     helping the body respond better to its own insulin
  • ●     lowering the amount of sugar (glucose) made by the body



  • ●     have a condition called diabetic ketoacidosis
  • ●     have ever had an allergic reaction to glipizide or any of the other ingredients in Glipizide ER. Ask your healthcare provider or pharmacist for a list of these ingredients.

  • ●     are taking or using any prescription medicines or nonprescription medicines, including natural or herbal remedies. Other medications can increase your chance of getting low blood sugar or high blood sugar. Be sure to tell your healthcare provider if you take the medicines miconazole or fluconazole, used to fight fungus infections.
  • ●     have ever had a condition called diabetic ketoacidosis
  • ●     have kidney or liver problems
  • ●     have had blockage or narrowing of your intestines due to illness or past surgery
  • ●     have chronic (continuing) diarrhea
  • ●     are pregnant or might be pregnant. Your healthcare provider may switch you to insulin injections some time during your pregnancy. You should not take Glipizide ER during the last month of pregnancy.
  • ●     are breast-feeding. Glipizide ER may pass to the baby through your milk and cause harm.


  • ●     Take Glipizide ER once a day with breakfast. The tablet is designed to release the medicine slowly over 24 hours. This is why you have to take it only once a day.
  • ●     Swallow the tablet whole. Never chew, crush, or cut the tablet in half. This would damage the tablet and release too much medicine into your body at one time.







  • ●     a cold clammy feeling
  • ●     hunger
  • ●     unusual sweating
  • ●     fast heartbeat
  • ●     dizziness
  • ●     headache
  • ●     weakness
  • ●     blurred vision
  • ●     trembling
  • ●     slurred speech
  • ●     shakiness
  • ●     tingling in the lips or hands


  • ●     feeling jittery
  • ●     diarrhea
  • ●     gas








PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Glipizide

Glipizide

Glipizide

Glipizide TABLET, FILM COATED, EXTENDED RELEASE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-272(NDC:0591-0844)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
GLIPIZIDE GLIPIZIDE 5 mg

Inactive Ingredients

Ingredient Name Strength
ACETYLTRIBUTYL CITRATE
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)
hydroxypropyl cellulose
lactose monohydrate
MAGNESIUM STEARATE
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
polyethylene glycol
FD&C YELLOW NO. 6
SHELLAC
ISOPROPYL ALCOHOL
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
propylene glycol
AMMONIA

Product Characteristics

Color Size Imprint Code Shape
orange 6 mm WPI;844 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-272-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076467 2011-06-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.